# Real Life Evaluation of SGLT2 Use in Type 1 Diabetes

> **NCT04819178** · — · WITHDRAWN · sponsor: **Steno Diabetes Center Copenhagen**

## Conditions studied

- Diabetic Ketoacidosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04819178
- **Lead sponsor:** Steno Diabetes Center Copenhagen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-06-01
- **Primary completion:** 2021-12-01
- **Final completion:** 2021-12-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Withdrawel of approvement of Dapagliflozin to type 1 diabetes
- **Last updated:** 2022-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04819178

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04819178, "Real Life Evaluation of SGLT2 Use in Type 1 Diabetes". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04819178. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*